Benutzer: Gast  Login
Titel:

Rational indication for docetaxel rechallenge in metastatic castration-resistant prostate cancer.

Dokumenttyp:
Journal Article; Article
Autor(en):
Heck, MM; Thalgott, M; Retz, M; Wolf, P; Maurer, T; Nawroth, R; Hatzichristodoulou, G; Gschwend, JE; Kubler, H
Abstract:
Study Type - Therapy (case series) Level of Evidence 4 What's known on the subject? and What does the study add? Docetaxel rechallenge has shown preserved anti-tumour activity and has therefore been proposed as an option for further treatment in patients with metastatic castration-resistant prostate cancer, who have shown a good response to first-line chemotherapy with docetaxel. The present study provides evidence of docetaxel activity in patients who were treated with full-dose (75 mg/m ) 3-we...     »
Zeitschriftentitel:
BJU Int
Jahr:
2012
Band / Volume:
110
Heft / Issue:
11 Pt B
Seitenangaben Beitrag:
E635-40
Sprache:
eng
Volltext / DOI:
doi:10.1111/j.1464-410X.2012.11364.x
PubMed:
http://view.ncbi.nlm.nih.gov/pubmed/22889368
Print-ISSN:
1464-4096
TUM Einrichtung:
Institut für Medizinische Statistik und Epidemiologie; Urologische Klinik und Poliklinik
 BibTeX